| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2803066002012 | 306600201 | ELIGARD PS.INJ.SOL 22.5MG/1.2ML PF.SYR. BTx1 kit x 2 PF.SYR [(1PF.SYR A) + 1 (PF.SYR B x 1,2 ml solv)] | 142.76 | 149.76 | 184.14 |
| 05/2018 | 2803066003019 | 306600301 | ELIGARD PS.INJ.SOL 45MG/1.2ML PF.SYR. BTx1 kit x 2 PF.SYR [(1PF.SYR A) + 1 (PF.SYR B x 1,2 ml solv)] | 283.15 | 287.39 | 341.19 |
For treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty
Leuprolide binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion.
~3 hours
* 27 L [intravenous bolus administration to healthy male volunteers]
* 8.34 L/h [healthy male receiving a 1-mg IV bolus]